Hungarian Conservative

The Ukrainian government is working on blacklisting 14 products by the Hungarian pharmaceutical company Richter. Foreign Minister Péter Szijjártó believes that this has no professional basis, only political, and spoke up against the planned bannings at the EU foreign ministers’ meeting in Luxembourg.

Hungarian pharmaceutical corporation Richter Gedeon Nyrt is strengthening its scientific foundation to achieve further international success in its most profitable and fastest-growing focus area, neuropsychiatry.

The collaboration between the Hungarian University and JASCO, focusing on pharmaceutical development, is in a promising area. The goal is for Hungary to become one of Europe’s top ten and the world’s top twenty-five innovators by 2030.

Dodik expressed gratitude for the budgetary support provided by the Hungarian government earlier this year to the Bosnian Serbs, which enabled the institutions to function smoothly. According to the plans, the predominantly Serb-populated region of Bosnia and Herzegovina aims to work on the development of the electrical grid, solar energy, and hydropower, as well as construct a pharmaceutical factory and improve infrastructure.

He also stated that next year the country will have sufficient resources, for the first time since the regime change, to meet the NATO obligation of allocating 2 per cent of GDP to defence spending.

Péter Szijjártó welcomed Novartis’ announcement that the Swiss pharmaceutical company is establishing a new regional research and development centre in Budapest, from where it will coordinate its research projects in Southern Europe and Africa.

The German pharmaceutical industry has reported energy shortages threatening the stability of production.

Roche to create 250 new jobs in Budapest.